Information you will find on this website includes, but is not limited to, the following:
ORIC is dedicated to cultivating a culture of ethics, integrity, and compliance with applicable laws, regulations, and policies. We invite faculty, staff, researchers, and students to contact us for assistance with training, policies, procedures, or consultations. Our office has an open-door policy; we welcome all calls, emails, and in-person inquiries.
The following UMCIRB informed consent templates have been revised:
Consent Letter for Expedited Survey Research v. 02.05.18
Consent for More than Minimal Risk Research v. 02.16.18
Consent for No More than Minimal Risk Research v. 02.05.18
Genetic Testing Addendum v. 02.05.18
Language for Use in a Sponsor's Consent Template v. 02.08.15
Parent Permission Form Template: No More than Minimal Risk Research v. 02.05.18
Please begin using these templates immediately and discard any old templates you may have stored on your desktop.
The revisions involve primarily changes to Vidant Health contact information and minor grammatical/editorial changes as needed. These revised templates can be found on our website as well as in ePIRATE.
The National Institutes of Health (NIH) Policy on the use of a single Institutional Review Board (sIRB) of record for multi-site research became effective January 25, 2018. This policy establishes the expectation that all sites participating in multi-site studies involving non-exempt human subjects research funded by the NIH will use a single Institutional Review Board (sIRB) to conduct the ethical review required by the Department of Health and Human Services regulations for the Protection of Human Subjects. This policy applies to the domestic sites of NIH-funded multi-site studies where each site will conduct the same protocol involving non-exempt human subjects research, whether supported through grants, cooperative agreements, contracts, or the NIH Intramural Research Program. It does not apply to career development, research training or fellowship awards.
This policy applies to domestic awardees and participating domestic sites. Foreign sites participating in NIH-funded, multi-site studies will not be expected to follow this policy.
Investigators are encouraged to consult with the Office of Research Integrity and Compliance (ORIC) prior to including an sIRB plan in their application if they have questions about whether or not ECU should cede IRB review to another IRB or assume the responsibility of being the IRB of record (Reviewing IRB).
You may review the NIH posting regarding sIRB review by clicking here.
If you have additional questions about the sIRB review process or IRB reliance agreements, please call the ORIC at 252-744-2914, or email your questions to email@example.com.
If you will be traveling internationally on behalf of ECU, please submit a completed International Travel form for export control review and approval. Please submit this form as soon as you become aware that you will be traveling internationally. Click here to access the form.